Biophore India Pharmaceuticals

Hyderabad, Telangana, India
Hybrid — also manufactures internal programs
Small Molecule API
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP ✓ HC GMP (1)

Quick Facts: Biophore India Pharmaceuticals

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Hyderabad, Telangana, India
Website
Modalities
Small Molecule API
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Biophore India Pharmaceuticals

Biophore India Pharmaceuticals makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://biophore.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Biophore India Pharmaceuticals FDA Inspection History

2024-04
NAI VAI OAI
Date Site Type Observations Classification
2024-04-26
Biophore India Pharmaceuticals Private Limited
Visakhapatnam Company-level
Drug Quality Assurance No No Action Indicated (NAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data. This company's careers site asks automated readers not to collect it (robots.txt), and we respect that.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Biophore India Pharmaceuticals

How many FDA inspections does Biophore India Pharmaceuticals have on record?
CDMO Signal tracks 1 FDA inspection for Biophore India Pharmaceuticals, sourced from the FDA inspection database. See the full inspection history above.
Has Biophore India Pharmaceuticals received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Biophore India Pharmaceuticals.
Does Biophore India Pharmaceuticals have a CDMO Signal Score?
Not yet. Biophore India Pharmaceuticals is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Biophore India Pharmaceuticals for a manufacturing program?
Use the free AI matchmaker to compare Biophore India Pharmaceuticals against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Sai Life Sciences
India
Small Molecule API
Coral Drugs
India
Small Molecule API
Aarti Pharmalabs
India
Small Molecule API
Anthem Biosciences
India
Small Molecule API, Peptides & Oligos, Biologics
Divi's Laboratories
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis, Peptides

Compare Biophore India Pharmaceuticals with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Biophore India Pharmaceuticals
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.